RecruitingPhase 3NCT07662135
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Sponsor: AstraZeneca
Sun City, AZ · Surprise, AZ · +31 more sites